Facing extinction, MannKind is reportedly looking to sell itself

Damian Garde

Struggling drugmaker is for a way out of its perilous financial situation, according to Reuters, scouting for a buyer in the wake of ex-partner Sanofi's decision to abandon the company and its inhaled insulin.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS